We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Issued for Nonclinical Studies of Drug Combinations
Guidance Issued for Nonclinical Studies of Drug Combinations
February 7, 2005
The FDA released a draft guidance Jan. 25 containing recommendations on nonclinical safety evaluations to support the clinical study and approval of fixed-dose combination products, co-packaged products and adjunctive therapies.